COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours SIG Group AG: Full year results 2025 - stable revenue in a challenging market environment; clear roadmap to drive future value creation SIG Group AG reports stable revenue for FY 2025 amidst challenging market conditions. Clear roadmap set for future value creation. Mikko Keto appointed new CEO Revenue Market Conditions SIG Group AG FY 2025 Mikko Keto
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours Annual results 2025 - Arbonia increases revenue and EBITDA and proposes Christoph Ganz as new Chairman of the Board of Directors Arbonia AG reports 12.3% revenue growth and EBITDA increase in 2025. Christoph Ganz proposed as new Chairman of the Board of Directors Board Of Directors EBITDA Revenue Growth Arbonia AG Christoph Ganz
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours VERAXA Biotech Receives 99.57% Approval for Merger - Path to NASDAQ Listing Under «VRXA» Cleared VERAXA Biotech gains 99.57% approval for merger with Voyager Acquisition Corp., paving the way for NASDAQ listing. Xlife Sciences AG supported the strategic development Merger Nasdaq Listing Xlife Sciences AG Cancer Therapies VERAXA Biotech
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours DocMorris AG announces changes to its Board of Directors DocMorris AG announces changes to its Board of Directors, with Prof. Stefan Feuerstein, Dr Christian Mielsch, and Rongrong Hu not standing for re-election, proposing the election of new members at the upcoming Annual General Meeting Board Of Directors Annual General Meeting Personnel Changes DocMorris AG New Members
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation MindMaze Therapeutics provides corporate update and publishes March 2026 investor presentation, focusing on expansion in the US and Europe, organizational restructuring, and governance changes Expansion Investor Presentation Corporate Update Neurological Diseases MindMaze Therapeutics
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours Sandra Maissen becomes partner at Dynamics Group Sandra Maissen joins Dynamics Group as partner, enhancing strategic communications and advocacy capabilities in Switzerland's political arena Partner Strategic Communications Dynamics Group Public Affairs Sandra Maissen
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours Sandra Maissen rejoint Dynamics Group comme Associée Sandra Maissen rejoint Dynamics Group en tant qu'Associée, renforçant ainsi la présence de l'entreprise à Berne et son rôle en communication stratégique et politique Dynamics Group Communication Stratégique Affaires Publiques Associée Sandra Maissen
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours SMA Group publishes preliminary, non-audited figures for 2025 as a whole and issues guidance for the 2026 fiscal year SMA Group releases preliminary 2025 figures with sales slightly down at €1,516.0 million and issues 2026 guidance with sales expected between €1,475 million to €1,675 million Sales SMA Group Restructuring Program 2025 Figures 2026 Guidance
COMMUNIQUÉ RÉGLEMENTÉ publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours Thales makes available its 2025 Financial Statements
COMMUNIQUÉ RÉGLEMENTÉ publié le 03/03/2026 à 07:00, il y a 6 mois 7 jours Thales met à disposition ses états financiers 2025
Publié le 10/09/2026 à 19:30, il y a 2 heures 15 minutes Availability of the 2026 Interim Financial Report
Publié le 10/09/2026 à 19:30, il y a 2 heures 15 minutes Mise à disposition du Rapport Financier Semestriel 2026
Publié le 10/09/2026 à 18:10, il y a 3 heures 35 minutes LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Publié le 10/09/2026 à 17:45, il y a 4 heures COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Publié le 10/09/2026 à 17:42, il y a 4 heures 2 minutes Déclaration d'actions et de droits de vote au 31.08.2026
Publié le 10/09/2026 à 15:20, il y a 6 heures 25 minutes MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 6 heures 45 minutes All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Publié le 10/09/2026 à 14:37, il y a 7 heures 8 minutes Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Publié le 10/09/2026 à 14:30, il y a 7 heures 15 minutes Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference
Publié le 10/09/2026 à 21:25, il y a 19 minutes Ørsted receives final opinion regarding taxation of Walney Extension and Hornsea 1
Publié le 10/09/2026 à 19:35, il y a 2 heures 9 minutes EQS-Adhoc: United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Publié le 10/09/2026 à 19:21, il y a 2 heures 23 minutes EQS-Adhoc: IONOS Group SE launches strategic transformation program and strengthens growth foundation
Publié le 10/09/2026 à 19:00, il y a 2 heures 45 minutes EQS-Adhoc: 1&1 AG approves transformation and restructuring program for 1&1 Versatel and adjusts its 2026 EBITDA forecast